Mei Tian, MD, PhD
Fudan University and Huashan Hospital
Mei Tian, MD, PhD, is a Distinguished Professor of Nuclear Medicine and Molecular Imaging, President of the Human Phenome Institute (HuPI), Director of the Center for Advancing Global Collaborations (CAGC), and Senior Clinical Consultant of the Department of Nuclear Medicine/PET Center, Huashan Hospital of Fudan University. She serves as the President of the World Molecular Imaging Society (WMIS), Vice President of the Chinese Society for Cognitive Science (CSCS).

Prof. Tian has been trained in Japan and worked at Dana-Farber Cancer Institute, Harvard Medical School, served as an Assistant Professor at MD Anderson Cancer Center, and was the Vice President of Zhejiang University Medical Center. With over 20 years of post-MD training and practice, Professor Tian has long been dedicated to clinical practice, teaching, and scientific research in the fields of radiology, nuclear medicine, and molecular imaging. Her research interests cover precise diagnosis of major human diseases such as aging, cancers, and neuro-psychiatric disorders. She has developed novel multi-modality molecular imaging technologies based on molecular recognition, precision PET imaging approaches, and smart probes for precise theranostics, as well as the integrative research on molecular imaging and human phenome.

She has published over 200 papers in international journals, including 4 international expert consensuses on molecular imaging. She serves as an Associate Editor for the official journals of three prominent international societies in nuclear medicine and molecular imaging. She is the chief editor of Nuclear Medicine (Chinese version), which is the national textbook for medical degree students, residents, and board-certified physicians.

Her outstanding achievements have earned her numerous honors, including the China Youth Science and Technology Award, the China Women in Science Award, the First Prize of the Ministry of Education Science and Technology Award, and multiple grants received from the academic societies, i.e., ASCO and RSNA.
Mei Tian, MD, PhD